Effectiveness of a Medication Wallet Card

NCT02820129 | Completed Phase 1

• 1 other identifier: TAPER-Wallet-Card-002-May-23
• Study Type: interventional
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study evaluates whether or not the use of a medication wallet card in patients over 70 taking 5 or more medications promotes self-efficacy with regards to coping with illness, understanding medications, and staying healthy. Half of the participants will receive an individualized medication wallet card with their medications and medical conditions listed while the other half will receive a simple reminder card.

Conditions

Comorbidity; Medication Therapy Management; Polypharmacy

Keywords

polypharmacy; wallet card; medication; self-efficacy; patient enablement

Outcome Measures

Primary Outcomes (2)

• Patient Enablement Index

  Patient Enablement Index

  4 weeks

• Patient Enablement Index

  Patient Enablement Index Repeated

  6 months

Secondary Outcomes (1)

• Usability - Qualitative Data

  4 weeks

Study Arms (2)

Wallet Card Group

EXPERIMENTAL

The intervention arm is comprised of: Patients from the TAPER study who receive a medication wallet card with their medications and medical conditions listed.

Device: Medication Wallet Card

Control Group

PLACEBO COMPARATOR

Standard of care as well as wait list control. These participants will receive a "reminder" wallet card which states, "Remember to keep an up-to-date listing of your medications and bring your medications to your doctor's appointments."

Device: Reminder Card

Interventions

Medication Wallet Card DEVICE

A medication wallet card will be given to the intervention group. This will be personalized for each patient and will include the patient's medications, dosages, and medical conditions. It will be personally given to a patient after a medical appointment with their family physician.

Wallet Card Group

Reminder Card DEVICE

A reminder card will be given to this group. The card will not be personal and will be mailed to patients. It will state, "Remember to keep an up-to-date listing of your medications and bring your medications to your doctor's appointments."

Also known as: Placebo Intervention

Control Group

Eligibility Criteria

• Age: 70 Years - 116 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Older Adult (65+)

You may qualify if:

• Aged 70 years of age or older
• Participating family doctor as most responsible provider
• Patient of McMaster Family Health Team
• Currently taking 5 or more medications
• Have not had a recent comprehensive medication review
• Patient consents

You may not qualify if:

• English language or cognitive skills inadequate to understand and respond to rating scales
• Terminal illness or other circumstance precluding 13 month study period

Sponsors & Collaborators

• McMaster University: lead

Related Publications (8)

• Hillestad R, Bigelow J, Bower A, Girosi F, Meili R, Scoville R, Taylor R. Can electronic medical record systems transform health care? Potential health benefits, savings, and costs. Health Aff (Millwood). 2005 Sep-Oct;24(5):1103-17. doi: 10.1377/hlthaff.24.5.1103.

  PMID: 16162551 BACKGROUND

• Varkey P, Cunningham J, Bisping DS. Improving medication reconciliation in the outpatient setting. Jt Comm J Qual Patient Saf. 2007 May;33(5):286-92. doi: 10.1016/s1553-7250(07)33033-x.

  PMID: 17503684 BACKGROUND

• Nassaralla CL, Naessens JM, Chaudhry R, Hansen MA, Scheitel SM. Implementation of a medication reconciliation process in an ambulatory internal medicine clinic. Qual Saf Health Care. 2007 Apr;16(2):90-4. doi: 10.1136/qshc.2006.021113.

  PMID: 17403752 BACKGROUND

• Gandhi TK, Weingart SN, Seger AC, Borus J, Burdick E, Poon EG, Leape LL, Bates DW. Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med. 2005 Sep;20(9):837-41. doi: 10.1111/j.1525-1497.2005.0194.x.

  PMID: 16117752 BACKGROUND

• Bandura A. Social cognitive theory: an agentic perspective. Annu Rev Psychol. 2001;52:1-26. doi: 10.1146/annurev.psych.52.1.1.

  PMID: 11148297 BACKGROUND

• Klein GL, Zenk KE. A Medical Allergy Profile (MAP) card. Ann Allergy. 1981 Jun;46(6):328-30.

  PMID: 7247083 BACKGROUND

• Chae SY, Chae MH, Isaacson N, James TS. The patient medication list: can we get patients more involved in their medical care? J Am Board Fam Med. 2009 Nov-Dec;22(6):677-85. doi: 10.3122/jabfm.2009.06.090059.

  PMID: 19897697 BACKGROUND

• Hudon C, Fortin M, Rossignol F, Bernier S, Poitras ME. The Patient Enablement Instrument-French version in a family practice setting: a reliability study. BMC Fam Pract. 2011 Jul 7;12:71. doi: 10.1186/1471-2296-12-71.

  PMID: 21736729 BACKGROUND

Study Officials

• Ainsley Moore, MD

  McMaster University, Department of Family Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 1
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 21, 2016
• First Posted: June 30, 2016
• Study Start: July 1, 2016
• Primary Completion: December 1, 2018
• Study Completion: December 1, 2018
• Last Updated: September 10, 2021

Record last verified: 2021-09

Data Sharing

• IPD Sharing: Will not share